Magle Chemoswed Holding AB (publ)

About Us

The Magle Group aims to establish itself as a leader in high-quality life-changing healthcare innovations to meet medical needs through scientific excellence. The Magle Group is founded on strategic acquisitions aimed at driving growth and diversifying risk. Today, the Group includes two operational areas. Magle Chemoswed – a contract development and manufacturing organization (CDMO) with a strong reputation for its high-quality development and manufacturing expertise and Magle PharmaCept – an established sales and marketing company for development and direct sales of the Groups medical technology products. Learn more on www.maglechemoswed.com and https://maglegroup.com/ and www.maglepharmacept.com

Pick a time period -

Tags ( Active)

All Regulatory Non-Regulatory

BioStock: How Magle Group focus their use of DSM

Wed, Aug 21, 2024 09:30 CET

The company aims to establish itself as a leader in life-changing healthcare innovations. Watch Justin Pierce, CEO and Helena Ossmer Thedius, Chief Marketing and Innovation Officer, explain their technology platform of degradable starch microspheres (DSM), serving as the base for development of new products, in BioStock Studio.Watch the interview at biostock.se /en/: https://www.biostock.se/?p=52215&preview=true This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/

There are no items matching the current filter

There are no more items matching the current filter

Share

About Us

BioStock: How Magle Group focus their use of DSM

Subscribe